Showing results (141-150 of 163) with videos related to

Sort By:
Pageof 17
Rheumatology (Oxford, England)|November 23, 2022
Machine learning identifies a profile of inadequate responder to methotrexate in rheumatoid arthritisJulien Duquesne, Vincent Bouget, Paul Henry Cournède, et al.
The International Journal on Drug Policy|February 14, 2026
Confiscations, public health obstructions, and perpetual displacement: Experiences and perspectives on urban law enforcement practices during a period of "recriminalization" among people who use criminalized drugsTyson Singh Kelsall, Caitlin Shane, Kelsey A Speed, et al.
ESC Heart Failure|January 20, 2021
Transient heart rate reduction improves acute decompensated heart failure-induced left ventricular and coronary dysfunctionNicolas Peschanski, Najah Harouki, Matthieu Soulie, et al.
Journal for Immunotherapy of Cancer|September 7, 2023
Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancerPierre Decazes, Samy Ammari, Younes Belkouchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2023
Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on ImmunotherapyYounes Belkouchi, Hugues Talbot, Nathalie Lassau, et al.
Emerging Infectious Diseases|November 25, 2014
Bacterial pathogens associated with hidradenitis suppurativa, FranceHélène Guet-Revillet, Hélène Coignard-Biehler, Jean-Philippe Jais, et al.
European Journal of Cancer (Oxford, England : 1990)|July 11, 2025
The correlation of liquid biopsy genomic data to radiomics in colon, pancreatic, lung and prostatic cancer patientsAntoine Italiano, Othilie Gautier, Jules Dupont, et al.
Journal for Immunotherapy of Cancer|November 29, 2024
Antecedent viral immunization and efficacy of immune checkpoint blockade: an extensive serum antibody profile to predict outcomes in non-small cell lung cancerFilippo G Dall'Olio, Wael Salem Zrafi, Quentin Blampey, et al.
Alimentary Pharmacology & Therapeutics|February 12, 2025
The Lipidomic Profile Discriminates Between MASLD and MetALDKai Markus Schneider, Feng Cao, Helen Ye Rim Huang, et al.
Cancer Discovery|March 26, 2026
Machine learning predicts hepatocellular carcinoma risk from routine clinical data: a large population-based multicentric studyJan Clusmann, Paul-Henry Koop, David Y Zhang, et al.
Pageof 17